Assisted Reproductive Technology clinical trials

Explore recruiting assisted reproductive technology clinical trials.

Recruiting assisted reproductive technology studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Assisted Reproductive Technology trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. APPART trial

France

Phase III and phase IV (Integrated) EU CTIS Study details

A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme

Italy, Spain

Phase III and phase IV (Integrated) EU CTIS Study details

SOLOAGO - Luteal phase support by GnRH agonist alone after GnRH agonist triggering compared to the reference protocol (hCG triggering and luteal support with progesterone) in IVF: a randomized controlled trial.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis: Randomised Prospective Study.

France

Phase III and phase IV (Integrated) EU CTIS Study details

Assisted reproductive technology (ART) and pregnancy outcomes in women with adenomyosis (internal endometriosis) according to stimulation protocol in relation to immunological and endometrial features: a prospective, randomized study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Assisted Reproductive Technology trials by city

Assisted Reproductive Technology in Toronto Assisted Reproductive Technology in Vancouver Assisted Reproductive Technology in Montreal Assisted Reproductive Technology in Calgary Assisted Reproductive Technology in Edmonton Assisted Reproductive Technology in Ottawa Assisted Reproductive Technology in Winnipeg Assisted Reproductive Technology in Quebec City Assisted Reproductive Technology in Hamilton Assisted Reproductive Technology in Kitchener Assisted Reproductive Technology in London Assisted Reproductive Technology in Halifax Assisted Reproductive Technology in New York Assisted Reproductive Technology in Los Angeles Assisted Reproductive Technology in Chicago Assisted Reproductive Technology in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease